InsiderInsights.com Daily Round Up 5/13/16: ACTG, CWEI, HTM

|
Includes: ABBV, ACTG, CERN, CHKE, CWEI, EL, HTM, LLY, LOV, LPX, MB, MDCO, MLM, MMC, NSP, NTLA, PJT, PRAA, SGLDF, SMG
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 5/13/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

On Today's Tables:

Insider trades were rated Significant at:

  • US Geothermal (NYSEMKT:HTM);
  • Clayton Williams Energy (NYSE:CWEI), and;
  • Acacia Research (NASDAQ:ACTG).

Insider trades were rated Nearly Significant at:

  • PJT Partners (NYSE:PJT), and;
  • PRA (NASDAQ:PRAA).

Insider trades were considered Insignificant at:

  • Shoal Games (OTCQB:SGLDF);
  • Spark Networks (NYSEMKT:LOV);
  • Cherokee (NASDAQ:CHKE);
  • Scotts Miracle Gro (NYSE:SMG);
  • Insperity (NYSE:NSP);
  • Marsh & McLennan (NYSE:MMC);
  • Martin Marietta (NYSE:MLM);
  • Louisiana-Pacific (NYSE:LPX);
  • Lilly Eli (NYSE:LLY), and;
  • AbbVie (NYSE:ABBV).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Medicines (NASDAQ:MDCO);
  • Mindbody (NASDAQ:MB);
  • Estee Lauder (NYSE:EL), and;
  • Cerner (NASDAQ:CERN).

There is an IPO or Known Corporate Action at:

  • Intellia Therapeutics (Pending:NTLA).

It's difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Eshelman Fredric N DIR Medicines MDCO B $10,104,000
2 Ares Mgt DIR,BO Clayton Williams Energy CWEI B $9,251,038
3 Orbimed Advisors DIR Intellia Therapeutics NTLA JB* $4,500,000
4 Roberts David N DIR Pra PRAA B $1,009,800
5 Taubman Paul J CB,CEO Pjt Partners PJT B $828,650
6 Williams Tryon M CB,DIR,BO Shoal Games SGLDF JB* $600,000
7 Graziadio G Louis DIR Acacia Research ACTG B $422,599
8 Headlands Strat Opps Fd BO Cherokee CHKE B $410,572
9 Jcp Investment Mgt BO Us Geothermal HTM B $371,347
10 Miller Lloyd I Iii BO Spark Networks LOV B $349,576
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Lal Family Partners BO Estee Lauder EL S $35,578,216
2 Lilly Endowment BO Lilly Eli LLY S $14,414,035
3 Beshar Peter J VP,GC Marsh & McLennan MMC AS $7,066,528
4 Sarvadi Paul J CB,CEO Insperity NSP S $4,330,808
5 Bessemer Venture Partners Vii DIR,BO Mindbody MB S $3,550,000
6 Hagedorn James CB,CEO,BO Scotts Miracle Gro SMG S $2,985,917
7 Nye C Howard CB,CEO,DIR Martin Marietta MLM S $2,497,440
8 Gonzalez Richard A CB,CEO Abbvie ABBV AS $2,488,200
9 Patterson Neal L CB,CEO Cerner CERN S $2,169,600
10 Stevens Curtis M CEO Louisiana Pacific LPX S $2,147,014
Click to enlarge

InsiderInsights.com | Key to Insider Title and Trans Type Codes:
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.